BUZZ-Valeant Pharmaceuticals International Inc: CEO on medical leave

Mon Dec 28, 2015 9:12am EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Embattled Canadian drugmaker's U.S.-listed shares down about 7 pct at $106.52 premarket

** Valeant says a group of company executives will take over in an interim capacity, until CEO Michael Pearson returns from medical leave

** Pearson was hospitalized with a "severe case of pneumonia" on Friday, a company spokeswoman said last week

** Valeant's board has created an "office of the Chief Executive Officer", which will include general counsel Robert Chai-Onn, group chairman Ari Kellen, and Chief Financial Officer Robert Rosiello

** Up to Thursday's close, stock had fallen about 20 pct this year